Medical innovation prize fund: new idea in drug development.
This proposal, now introduced in Congress as HR 417, would replace current drug marketing with system better designed to reward effective innovation. All drugs would be treated as generics immediately when approved by the FDA, and patent holders would be rewarded from a $60 billion a year award fund for innovations that actually led to better health.
James
John S
JS
D001363:Awards and Prizes; D016527:Drug Costs; D015195:Drug Design; D004345:Drug Industry; D011057:Politics; D014481:United States